We should judge on the response to the challenges,
Post# of 148172
(Total Views: 633)
Posted On: 07/13/2020 10:57:38 AM
We should judge on the response to the challenges, not just that challenges occur. The vast majority here (including me) have absolutely no idea what is involved in FDA BLA and NDA processes.
This company of fewer than two dozen employees has brought a drug of unfathomable potential to this point. Doubtless they trusted Amarex to perform flawlessly in shepherding leronlimab through the BLA. Obviously this did not happen.
The sky has not fallen. The stock price fell hard this morning but is rebounding. It appears that many panicked and others benefited.
We will see the response at 1600 today to BLA disappointment, but Covid trial results will come regardless.
This company of fewer than two dozen employees has brought a drug of unfathomable potential to this point. Doubtless they trusted Amarex to perform flawlessly in shepherding leronlimab through the BLA. Obviously this did not happen.
The sky has not fallen. The stock price fell hard this morning but is rebounding. It appears that many panicked and others benefited.
We will see the response at 1600 today to BLA disappointment, but Covid trial results will come regardless.
(3)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼